More precisely, Stubbe et al. were able to show a significant association between hypermethylated SFRP1 in cell-free DNA and poor responsiveness to gemcitabine therapy in stage IV pancreatic cancer [27]. Here, SFRP1 is linked to familial pancreatic carcinoma.